Table IV.
Quantitation of Angiogenic Response at Day 12 of Incubation
| Treatment | Number | Number of intersection points (mean ± SD) | Microvessel density | |||
|---|---|---|---|---|---|---|
| % | ||||||
| PBS | 20 | 0 | 0 | |||
| bFGF | 20 | 30 ± 2.4 | 22.2 | |||
| Purified ovotransferrin | 30 | 35 ± 5.1 | 24.3 | |||
| Chicken ovotransferrin | 30 | 22 ± 4.4 | 15.3* | |||
| Human apotransferrin | 30 | 18 ± 2.6 | 12.5* | |||
| Concentrated conditioned medium | 30 | 30 ± 7.2 | 20.8‡ | |||
| Not concentrated conditioned medium | 30 | 25 ± 4.8 | 17.4* |
P < 0.001 vs purified ovotransferrin.
P < 0.01 vs purified ovotransferrin.